Advances in the development of N-acylbenzo[d][1,2,3]diazaborinin-1(2H)-ols as antibacterial agents by synthesis, characterization, and antimicrobial assay
- 11 April 2026
- journal article
- Published by Springer Nature in Medicinal Chemistry Research
- Vol. 35 (4) , 847-862
Abstract
The ability of bacteria to quickly adapt to environmental stresses, such as exposure to antimicrobial drugs, has necessitated a continued search for novel antibacterial agents with new mechanisms of attack, forever in competition with the rate of adaptation of these pathogens. Antibiotic resistant strains of a multitude of infectious diseases have appeared, imposing a huge burden from diseases once believed to have been reduced to minor health issues. Building on prior work, twenty-one new N-acyl-1-hydroxy-2,3,1-benzodiazaborinines were synthesized and characterized by high-field NMR, FTIR, ESI-MS, and other methods including X-ray crystallography for one unexpected structure. The syntheses by direct condensation using acylhydrazides gave products found to exist in one of three structural forms connected by (de/re)hydration reactions: open hydrazone (a), boron heterocycle (b), and anhydro dimer (c). Multisolvent 1H and 13C NMR analyses showed that in solution these forms can readily interconvert in a solvent-dependent manner. The unanticipated structure of one target was established to be a rare ammonium borate salt arising from an extremely facile intramolecularly boron-catalyzed primary amide group hydrolysis. The new compounds were screened for activity against Escherichia coli in disk diffusion assays and seven of them demonstrated inhibitory activity, thus advancing the development of boron heterocycles towards the goal of producing next-generation antibacterial agents to combat persistently evolving resistant strains.Keywords
Funding Information
- California State University, East Bay (RSCA Faculty Support Grants)
- National Science Foundation (MRI 0420615)
- University of Tennessee (Ziegler Fund)
- National Institutes of Health (NIGMS SC3GM83686)
- Army Research Office (W911NF-12-1-0059)
This publication has 26 references indexed in Scilit:
- Boron-Containing heterocycles as promising pharmacological agentsBioorganic & Medicinal Chemistry, 2022
- Boron in drug design: Recent advances in the development of new therapeutic agentsEuropean Journal of Medicinal Chemistry, 2019
- Identification of cellular targets of a series of boron heterocycles using TIPA II—A sensitive target identification platformBioorganic & Medicinal Chemistry, 2016
- Synthesis, Characterization, and Antibacterial Activity of Structurally Complex 2‐Acylated 2,3,1‐Benzodiazaborines and Related CompoundsChemistry & Biodiversity, 2014
- A disk-diffusion-based target identification platform for antibacterials (TIPA): an inducible assay for profiling MOAs of antibacterial compoundsApplied Microbiology and Biotechnology, 2014
- Boron Heterocycles as Platforms for Building New Bioactive Agents2000
- Syntheses and evaluation of benzodiazaborine compounds against M. tuberculosis H37Rv in vitroBioorganic & Medicinal Chemistry Letters, 1998
- In vitro evaluations of amikacin: an assessment of the currently used methods of disk diffusion and dilution susceptibility, antimicrobial synergy, and the measurement of amikacin concentrationsThe American Journal of Medicine, 1986
- Nitrone von 2-formylphenylboronsäureesternJournal of Organometallic Chemistry, 1983
- Sur une nouvelle série de réactifs du groupe carbonyle, leur utilisation à l'extraction des substances cétoniques et à la caractérisation microchimique des aldéhydes et cétonesHelvetica Chimica Acta, 1936